Bicarbonate

Bicarbonate

SCHEMBL1127897

CCC.CCC.O=C(O)O.O=C(O)O.OO

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 3/20 0.58
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
HDAC1 Q13547 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC3 O15379 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
TDP1 Q9NUW8 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
CHRM1 P11229 1/20 0.39
AKR1A1 P14550 1/20 0.39
CHRM3 P20309 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL591922 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL28893179 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL28363045 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL288699 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL10955970 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL2497150 1.00 FFAR3 (0.58) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL7151962 1.00
Bicarbonate SCHEMBL20586919 0.95 FFAR3 (0.54) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL9435869 0.95 FFAR3 (0.54) FFAR3CA1CA2CA9HDAC1
Bicarbonate SCHEMBL17023327 0.95 FFAR3 (0.54) FFAR3CA1CA2CA9HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433077-A Preparation of 11-bromo-undecylic acid from 10-undecylenic acid and preparation method thereof 中国五环工程有限公司 2022-12-06 CN claimed
EP-4318680-A1 NEGATIVE ELECTRODE PLATE AND PREPARATION METHOD THEREFOR, SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND ELECTRIC DEVICE Contemporary Amperex Technology Co., Limited (CN) 2024-02-07 EP disclosed
CN-115433077-A Preparation of 11-bromo-undecylic acid from 10-undecylenic acid and preparation method thereof 中国五环工程有限公司 2022-12-06 CN disclosed
CN-110651383-B Separator without separator substrate and electrochemical device comprising same 株式会社LG新能源 2022-11-29 CN disclosed
CN-112898714-A Preparation and application of multifunctional efficient PVC modified processing aid 广东鑫达新材料科技有限公司 2021-06-04 CN disclosed
CN-111819218-A Prepreg, laminate, multilayer printed wiring board, semiconductor package, resin composition, and methods for producing prepreg, laminate, and multilayer printed wiring board 日立化成株式会社 2020-10-23 CN disclosed
US-9669243-B2 Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrate BASF SE (DE) 2017-06-06 US disclosed
EP-2109441-B1 POLYSILOXANE BLOCK COPOLYMERS BASF SE (DE) 2016-01-27 EP disclosed
US-8378038-B2 Polysiloxane block copolymers BASF SE (DE) 2013-02-19 US disclosed
CN-101616658-B Polysiloxane block copolymers CIBA HOLDING INC CH 2012-11-14 CN disclosed
US-20080199418-A1 Polysiloxane block copolymers BASF SE (DE) 2008-08-21 US disclosed
WO-2008095822-A2 POLYSILOXANE BLOCK COPOLYMERS CIBA HOLDING INC. (CH) 2008-08-14 WO disclosed
US-20080033106-A1 Composition for improving wettability of surfaces CIBA SPECIALTY CHEMICALS CORP. 2008-02-07 US disclosed
WO-2008015136-A1 BLOCK COPOLYMERS OF DIALLYLDIALKYLAMMONIUM DERIVATIVES CIBA HOLDING INC. (CH) 2008-02-07 WO disclosed
US-20080033115-A1 Block copolymers of diallyldialkylammonium derivatives CIBA SPECIALTY CHEMICALS CORP. 2008-02-07 US disclosed
WO-2008015138-A2 COMPOSITION FOR IMPROVING WETTABILITY OF SURFACES CIBA HOLDING INC. (CH) 2008-02-07 WO disclosed
US-7067587-B2 Polyolefin macromonomer, graft polymer obtained from the polyolefin macromonomer, and use thereof MITSUI CHEMICALS, INC. (JP) 2006-06-27 US disclosed
US-20040242791-A1 Polyolefin macromonomer, graft polymer obtained from the polyolefin macromonomer, and use thereof MITSUI CHEMICALS, INC. (JP) 2004-12-02 US disclosed
EP-1396504-A2 Polyolefin macromonomer, graft polymer obtained from the polyolefin macromonomer, and use thereof Mitsui Chemicals, Inc. (JP) 2004-03-10 EP disclosed
CN-1107649-A Plexiglass specimen embedding method and its formula DUAN YONGFU (CN) 1995-09-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080199418-A1 Polysiloxane block copolymers KRT18, PUF60, SCNN1B FFAR3 2104/4885CA1 1573/4885CA2 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.